Metformin Guide (2026)
Complete Guide & Evidence (2026)
First-line Type 2 diabetes drug now studied for longevity (TAME trial). Activates AMPK, reduces insulin/IGF-1 signaling, and has anti-cancer properties.
How Metformin Works
AMPK Activation
Activates the cellular energy sensor AMPK. Mimics caloric restriction signaling. Reduces hepatic glucose production
mTOR Inhibition
Indirectly inhibits mTORC1 via AMPK. Promotes autophagy โ cellular cleanup. Reduces protein synthesis โ longevity signal
Metabolic Effects
Improves insulin sensitivity. Lowers fasting glucose and HbA1c. Mild reduction in body weight (1โ3 kg)
Metformin Protocol Overview
Monitor: Annual B12 levels, eGFR, HbA1c. Avoid on days of heavy exercise (controversial) and hold before contrast imaging. Use extended-release to minimize GI side effects.
Metformin Longevity Research Timeline
Metformin first described in France. Used for T2D in Europe from 1958.
NEJM paper: diabetics on metformin outlive matched non-diabetics โ landmark longevity signal.
FDA approves TAME (Targeting Aging with Metformin) trial protocol โ first FDA-approved aging trial.
TAME trial actively enrolling ~3,000 healthy adults aged 65โ79. Results expected 2027.
Vital Protocol FAQs
Why are healthy people taking metformin for longevity?
Metformin, the most prescribed diabetes drug in the world, has attracted longevity interest because of its AMPK activation (same pathway as caloric restriction), mTOR inhibition, and observational dat
What is the metformin longevity dose?
For longevity purposes (off-label), physicians typically prescribe 500โ1000 mg/day, often taken at night or with meals to minimize GI side effects. The TAME trial uses 1500 mg/day. Diabetic doses go u
Does metformin interfere with exercise adaptations?
This is a genuine controversy. A 2023 study showed high-dose metformin blunted some exercise adaptations (VO2max gains) in older adults. However, lower doses and specific timing (avoiding pre-workout
Is metformin safe for non-diabetics?
Metformin has a very long safety record with billions of patient-years of use in diabetics. The primary risk in non-diabetics is hypoglycemia (rare at low doses) and vitamin B12 depletion with long-te
Guide FAQs
First-line Type 2 diabetes drug now studied for longevity (TAME trial). Activates AMPK, reduces insulin/IGF-1 signaling, and has anti-cancer properties.
Yes. Shotlee supports tracking Metformin doses, side effects, and health metrics. It is free to use.
References
- [1]Clinical TrialUK Prospective Diabetes Study (UKPDS) Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet. 1998;352(9131):854-865.
- [2]Clinical TrialKnowler WC et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin (DPP). N Engl J Med. 2002;346(6):393-403.
Track Your Metformin Protocol in Shotlee
Free dose logging, side effect tracking, and health metric monitoring for your complete protocol.
๐ Use Shotlee for Free